BioCentury on BioBusiness,
Sanofi-Medco, AstraZeneca-HealthCore bring payer side into clinical development
Payers in product development
Monday, August 1, 2011
Randomized, controlled trials are the gold standard for
regulatory approval, but they do not necessarily provide what payers want to
see: evidence of benefit in the real-world setting. Sanofi's
global partnership with Medco
Health Solutions Inc. is the latest pharma collaboration with the
reimbursement side aimed at designing trials and mining data to ensure that
payers get the answers they need at product launch.
The Sanofi-Medco deal, signed in June, echoes a collaboration
plc and HealthCore Inc., the outcomes research subsidiary of health
benefits company WellPoint
Inc. Under that February deal, HealthCore will conduct real-world
studies in the U.S. to determine the value of a medicine to the total
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]